We are live on ! Find out more
SGP

SpyGlass Pharma
SGP

35 hedge funds and large institutions have $655M invested in SpyGlass Pharma in 2026 Q1 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.85% more ownership

Funds ownership: 0% → 75.85% (+76%)

Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
0.43%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$216M
2
NMC
NEA Management Company
Maryland
+$199M
3
SCV
Sands Capital Ventures
Virginia
+$67.3M
4
SB
Samsara BioCapital
California
+$56.8M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$19M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$208M +$216M +8,021,117 New
NMC
2
NEA Management Company
Maryland
$192M +$199M +7,392,301 New
SCV
3
Sands Capital Ventures
Virginia
$64.8M +$67.3M +2,500,012 New
SB
4
Samsara BioCapital
California
$54.7M +$56.8M +2,109,953 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$18.3M +$19M +704,440 New
VPC
6
Vestal Point Capital
New York
$17.3M +$17.9M +666,760 New
DM
7
Deerfield Management
New York
$14.3M +$14.8M +550,000 New
JP Morgan Chase
8
JP Morgan Chase
New York
$13.5M +$15.5M +577,109 New
Millennium Management
9
Millennium Management
New York
$12.1M +$12.6M +468,794 New
VCM
10
Vanguard Capital Management
Pennsylvania
$11.3M +$11.7M +434,813 New
FLAM
11
First Light Asset Management
Minnesota
$9.72M +$10.1M +375,000 New
Franklin Resources
12
Franklin Resources
California
$7.77M +$8.07M +300,000 New
AAA
13
Affinity Asset Advisors
New York
$6.48M +$6.73M +250,000 New
Aberdeen Group
14
Aberdeen Group
United Kingdom
$5.71M +$5.93M +220,454 New
BlackRock
15
BlackRock
New York
$3.75M +$3.89M +144,739 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.28M +$3.4M +126,540 New
MIM
17
Monashee Investment Management
Massachusetts
$2.46M +$2.56M +95,000 New
VFT
18
Vanguard Fiduciary Trust
Pennsylvania
$1.55M +$1.61M +59,782 New
Charles Schwab
19
Charles Schwab
California
$1.54M +$1.6M +59,610 New
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$1.48M +$1.53M +57,000 New
TD Asset Management
21
TD Asset Management
Ontario, Canada
$1.23M +$1.28M +47,580 New
Ameriprise
22
Ameriprise
Minnesota
$1.15M +$1.2M +44,477 New
Marshall Wace
23
Marshall Wace
United Kingdom
$760K +$790K +29,348 New
Bank of America
24
Bank of America
North Carolina
$726K +$754K +28,020 New
Northern Trust
25
Northern Trust
Illinois
$541K +$561K +20,862 New
1
2

SGP Hedge Fund Activity: Q1 2026 in Review

35 of the 8,138 institutional investors tracked by Wall St. Rank reported a position in SpyGlass Pharma (SGP) for Q1 2026, worth a combined $655M.

Buyers outnumbered sellers: 35 funds opened new SGP positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $216M.

  • 35 institutional investors held SpyGlass Pharma (SGP) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $655M of SpyGlass Pharma stock for Q1 2026.
  • 35 funds opened new SpyGlass Pharma positions in Q1 2026 and 0 closed out, a net change of +35 holders.
  • The largest SpyGlass Pharma buyer in Q1 2026 was RA Capital Management, an estimated $216M added.

Based on aggregated 13F filings for Q1 2026.